Introduction
Potassium-selective channels are the largest and most diverse group of ion channels, represented by some 70 known loci in the mammalian genome. The first cloned potassium channel gene was the Drosophila voltagegated shaker channel, and this was rapidly followed by the identification of other voltage-and ligand-gated potassium channel genes in flies, mammals, and many other organisms. The voltage-gated K v channels, in turn, form the largest family of some 40 genes among the group of human potassium channels, which also includes the Ca 2ϩ -activated (K Ca ), inward-rectifying (K IR ), and two-pore (K 2P ) families described in the following articles of this compendium. K v and K Ca channels together constitute the six/seven-transmembrane group of potassium-selective channels, made up of subunits containing six or seven membrane-spanning domains, including the positively charged S4 segment, which confers on some of these channels their voltage sensitivity. Table 1 K v channels form an exceedingly diverse group, much more so than one would predict simply based on the number of distinct genes that encode them. This diversity arises from several factors. 1) Heteromultimerization. Each K v gene encodes a peptide subunit, four of which are required to form a functional channel. K v channels may be homotetramers but may also be heterotetramers formed between different subunits within the same family (in the case of the K v 1, K v 7, and K v 10 families), and these diverse heterotetramers express properties that may be considerably different from those of any of the homotetramers. 2) "Modifier" subunits. Four of the K v families (K v 5, 6, 8, and 9) encode subunits that act as modifiers. Although these do not produce functional channels on their own, they form heterotetramers with K v 2 family subunits, increasing the functional diversity within this family. 3) Accessory proteins. A variety of other peptides has also been shown to associate with K v tetramers and modify their properties, including several ␤ subunits (which associate with K v 1 and K v 2 channels), KCHIP1 (K v 4), calmodulin (K v 10), and minK (K v 11), as well as many others identified in the tables that follow the text of this article. 4) Alternate mRNA splicing. A number of K v channel genes are known to contain intronless coding regions, including all of the K v 1 family genes (with the sole exception of K v 1.7) and K v 9.3. Although alternate splicing of noncoding exons may be important in regulating the expression of these channels, one gene can produce only a single kind of protein subunit. However, various members of the K v 3, 4, 6, 7, 9, 10, and 11 gene families have coding regions made up of several exons that are alternately spliced, providing yet another significant source of K v channel functional diversity. 5 Our current understanding of the roles of this family of channels is catalogued in Tables 2 through 41, FIG. 1. Phylogenetic tree for the K v 1-9 families. Amino acid sequence alignments of the human channel K v proteins were created using CLUSTALW, and analysis by maximum parsimony using PAUP* resulted in unrooted trees comprising the K v 1-K v 6 and K v 8-K v 9 families that appeared in the previous edition of this compendium. Sequences of K v 7.1-7.5, K v 6.4, and K v 8.2 were added to the existing alignment, and these new sequences were incorporated into the existing tree topology by use of a combination of maximum parsimony and neighbor-joining analysis. Only the hydrophobic cores (S1-S6) were used for analysis. The IUPHAR and HGNC names are shown together with the genes' chromosomal localization and other commonly used names.
FIG. 2.
Phylogenetic tree for the K v 10 -12 families. This unrooted tree was created as described in Fig. 1 and appeared in the previous edition of this compendium. The IUPHAR and HGNC names are shown together with the genes' chromosomal localization and other commonly used names.
Ion selectivity K ϩ (1) Ͼ Rb ϩ (0.8) Ͼ NH 4 ϩ (0.1) Activation V a ϭ Ϫ32 mV; k a ϭ 8.5 mV; n ϭ 5 ms (Ϫ32 mV) 20, 21 Inactivation V h ϭ Ϫ51 mV; k h ϭ 3 mV; h ϭ 11 s (40 mV) 20 Channel distribution Brain, heart, retina, skeletal muscle, islets [27] [28] [29] [30] [31] Physiological functions Maintaining membrane potential, modulating electrical excitability in neurons and muscle Mutations and pathophysiology Episodic ataxia/myokymia syndrome type 1 8, [32] [33] [34] Pharmacological significance Not established Comments K V 1.1 can coassemble with others in the K V 1 family members in heteromultimers, but not with members of other K V families; intronless coding region; mammalian Shaker-related family aa, amino acids; chr., chromosome; DTX, dendrotoxin; ShK, Stychodactyla helianthus toxin; BgK, Bundosoma granulifera toxin. 13. Stephens GJ, Cockett MI, Nawoschik SP, Schecter LE, and Owen DG (1996) The modulation of the rate of inactivation of the mKv1.1K ϩ channel by the ␤ subunit, Kv␤1 and lack of effect of a Kv␤1 N-terminal peptide. FEBS Lett 378:250 -252.
14. Heinemann SH, Rettig J, Graack HR, and Pongs O (1996) Functional characterization of Kv channel ␤-subunits from rat brain. 17. Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, Trimmer JS, Shrager P, and Peles E (1999) Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K ϩ channels. 14. Topinka JR and Bredt DS ( 18. Polliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, Trimmer JS, Shrager P, and Peles E (1999) Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K ϩ channels. Neuron 24:1037-1047. Brain (cerebellum Ͼ globus pallidus, subthalamic nucleus, substantia nigra Ͼ reticular thalamic nuclei, cortical and hippocampal interneurons Ͼ inferior colliculi, cochlear and vestibular nuclei), skeletal muscle, human Louckes B cells, germ cell, lung, testis, AtT20 cell line [9] [10] [11] [12] [13] 19, 20 Physiological functions Important for the high-firing frequency of auditory 8 and fast-spiking GABAergic interneurons 11, 21 ; regulation of action potential duration in presynaptic terminals 17, 18 Mutations and pathophysiology Kv3.1Ϫ/Ϫ mice exhibit impaired motor skills and reduced muscle contraction force 13 ; Kv3.1/Kv3.3 double knockout mice display severe ataxia, myoclonus, and hypersensitivity to ethanol Physiological functions Probably in heteromeric complexes with K V 3.1; important for the high-frequency firing of fast spiking GABAergic interneurons 17 and GABA release via regulation of action potential duration in presynaptic terminals 18 ; modulated by protein kinase A in vitro and in vivo 10, 20 Mutations and pathophysiology See "Comments" Pharmacological significance Not established Comments Fast deactivation; knockout mice show specific alterations in their cortical electroencephalographic patterns and an increased susceptibility to epileptic seizures consistent with an impairment of a cortical inhibitory mechanism 15 ; mammalian Shaw-related family aa, amino acids; chr., chromosome; D-NONOate, 1,1-diethyl-2-hydroxy-2-nitrosohydrazine; ShK, Stychodactyla helianthus toxin. The K v 4.1 (KCND1) gene is encoded by at least 6 exons 2 -the first exon encodes the protein from the N terminus through S5 into the P-region, whereas the remainder of the protein is encoded by exons 2-6; kinetic properties depend on the expression system, recording configuration, and the presence of auxiliary subunits (KChIPs) 4, 11 ; mammalian Shal-related family aa, amino acids; chr., chromosome. Radioligands None Channel distribution Infant brain, adult brain, fetal brain, sympathetic ganglia, lung, testis, fetal heart, adult heart, breast, eye, germ cell, placenta, small intestine, neuroblastoma 10 Physiological functions Determines subthreshold excitability of neurons; KCNQ2 and KCNQ3 coassemble to form the M current in the brain 1 (see "Comments"); KCNQ2 and KCNQ3 proteins are colocalized in a somatodendritic pattern on pyramidal and polymorphic neurons in the human cortex and hippocampus 11 ; KCNQ2 is also expressed in the absence of KCNQ3 in some presynaptic terminals 11 Mutations and pathophysiology Benign familial neonatal convulsions (EBN1) with myokymia 6, 7 ; in KCNQ2 knockout mice, homozygotes (KCNQ2Ϫ/Ϫ) die within a few hours after birth owing to pulmonary atelectasis that is not due to the status of epileptic seizures, although their development is morphologically normal; heterozygous mice have decreased expression of KCNQ2 and show hypersensitivity to pentylenetetrazole, an inducer of seizure 12 
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Pharmacological significance
Retigabine is an anticonvulsant 2 (the M current is a new target for antiepileptic therapy 8, 9 ); blockers enhance learning and memory in animal models 9 
Comments
The M current is a slowly activating and deactivating potassium conductance that plays a critical role in determining the subthreshold excitability of neurons as well as the responsiveness to synaptic inputs; the M current was first described in peripheral sympathetic neurons, and differential expression of this conductance produces subtypes of sympathetic neurons with distinct firing patterns; the M current is also expressed in many neurons in the central nervous system Determines subthreshold excitability of neurons; KCNQ2 and KCNQ3 coassemble to form the M current in the brain 1 (see "Comments"); KCNQ2 and KCNQ3 proteins are colocalized in a somatodendritic pattern on pyramidal and polymorphic neurons in the human cortex and hippocampus 7, 8 Mutations and pathophysiology Benign familial neonatal convulsions (EBN2) (e.g., G263V mutation in the pore) 9 Pharmacological significance Anticonvulsants (activators), cognition enhancers (blockers) 6 
The M current is a slowly activating and deactivating potassium conductance that plays a critical role in determining the subthreshold excitability of neurons as well as the responsiveness to synaptic inputs; the M current was first described in peripheral sympathetic neurons, and differential expression of this conductance produces subtypes of sympathetic neurons with distinct firing patterns; the M current is also expressed in many neurons in the central nervous system Mediates potassium efflux from outer hair cells 1, 6 Mutations and pathophysiology Mutations in KCNQ4 cause autosomal dominant nonsyndromic deafness type 2 (DFNA2) 1, 6 Pharmacological significance Anticonvulsants (activators) 3, 26 ; in the heart, HERG channels produce a resurgent current during repolarization 20 due to the recovery from C-type inactivation 4 and a slow deactivation due to an interaction with an N-terminal domain (AA2-16) and the internal mouth of the pore 1, 22 ; HERG contains a tetramerization domain called NAB and a structurally defined PAS domain in distinct regions of the N terminus 17 ; HERG forms a complex with MiRP1, 10 but it is as yet unclear whether MiRP1 forms a stable part of the channel itself or is otherwise involved in regulation of HERG expression or stability 23 Mutations and pathophysiology Mutations of this gene cause the autosomal dominant long QT syndrome 2 due to gating defects 28 and trafficking abnormalities [29] [30] [31] [32] [33] and a prolonged QT interval on the electrocardiogram; syncope, sudden cardiac death, ventricular fibrillation, and torsades de pointes are also implicated in acquired long QT syndrome; mutations in MiRP1 are the cause of long QT syndrome 6 and are also found in many tumors 18, 19 Pharmacological significance Proarrhythmic potential (QT prolongation) of histamine H 1 receptor antagonists, antipsychotics, and tricyclic antidepressants that leads to torsades de points in some individuals (acquired long QT syndrome) Comments A shorter isoform encoded by an alternative transcript (1b) of K v 11.1 5, 7 or a truncated isoform 6 can coassemble with and modulate the behavior of full-length HERG and Merg1, the mouse ortholog; the TCC domain at the C-terminal end of K v 10 and K v 11 confers specificity for multimer formation, allowing K v 10.1/K v 10.2 heteromerization and K v 11 homomerization, but not K v 10.x/ K v 11.x heteromerization 24 ; this C-terminal TCC domain has been identified in many other channels, and mutations of the TCC are found to be linked to genetic channelopathies; C terminus interacts with Golgi matrix protein GM130 34 
